John Metcalfe

Clinical characteristics and treatment outcomes of patients with isoniazid-monoresistant tuberculosis.

Evaluation of quantitative IFN-gamma response for risk stratification of active tuberculosis suspects.

Clinical and radiographic factors do not accurately diagnose smear-negative tuberculosis in HIV-infected inpatients in Uganda: a cross-sectional study.

Determinants of multidrug-resistant tuberculosis clusters, California, USA, 2004-2007.

Impact of isoniazid resistance-conferring mutations on the clinical presentation of isoniazid monoresistant tuberculosis.

Test variability of the QuantiFERON-TB gold in-tube assay in clinical practice.

Microscopic-observation drug-susceptibility assay for the diagnosis of drug-resistant tuberculosis in harare, zimbabwe.

A transcriptional signature for active TB: have we found the needle in the haystack?

Rapid molecular testing for TB to guide respiratory isolation in the U.S.: a cost-benefit analysis.

Impact of GeneXpert MTB/RIF on patients and tuberculosis programs in a low-burden setting. a hypothetical trial.

Reproducibility of interferon gamma (IFN-γ) release Assays. A systematic review.

Xpert MTB/RIF false detection of rifampin-resistant tuberculosis from prior infection.

Suboptimal specificity of Xpert MTB/RIF among treatment-experienced patients.

Quantifying Isoniazid Levels in Small Hair Samples: A Novel Method for Assessing Adherence during the Treatment of Latent and Active Tuberculosis.

A multi-analyte panel for non-invasive pharmacokinetic monitoring of second-line anti-tuberculosis drugs.

Tuberculosis progression rates in U.S. Immigrants following screening with interferon-gamma release assays.

Defining a Cutoff for Atazanavir in Hair Samples Associated With Virological Failure Among Adolescents Failing Second-Line Antiretroviral Treatment.

Mycobacterium tuberculosis Subculture Results in Loss of Potentially Clinically Relevant Heteroresistance.

Effect of Xpert MTB/RIF on clinical outcomes in routine care settings: individual patient data meta-analysis.

Point of care Xpert MTB/RIF versus smear microscopy for tuberculosis diagnosis in southern African primary care clinics: a multicentre economic evaluation.

Simultaneous analysis of 11 medications for drug resistant TB in small hair samples to quantify adherence and exposure using a validated LC-MS/MS panel.

More should be done now for patients with TB-associated chronic lung disease.

Correlation of Linezolid Hair Concentrations with Plasma Exposure in Patients with Drug-Resistant Tuberculosis.

Presentation and outcome of suspected sepsis in a high-HIV burden, high antiretroviral coverage setting.